Search This Blog

Thursday, December 4, 2025

Jan. 6 pipe bomb suspect started building devices in 2019, feds say

  A suspect arrested Thursday morning and charged with planting pipe bombs outside the Democratic and Republican National Committees on the eve of the Jan. 6, 2021, Capitol riot started building the deadly devices in 2019, federal investigators say.

Brian Cole Jr., 30, of Woodbridge, Va., was charged with one count of transporting explosives across state lines with intent to kill, injure and cause damage and one count of attempted malicious destruction — with authorities saying more charges were possible.

“You’re not going to walk into our capital city, put down two explosive devices and walk off into the sunset,” FBI Deputy Director Dan Bongino, who has made the case a priority since taking office in March, told reporters at an afternoon news conference. “Not gonna happen.

Washington, DC pipe bomb suspect Brian Cole Jr. seen in a picture posted on social media by his mother.
A suspect has been arrested in connection with the planting of pipe bombs outside the Democratic and Republican National Committees on the eve of the Jan. 6, 2021, Capitol riot.FBI

“We were gonna track this person to the end of the earth. There was no way he was getting away.”

Federal agents swarmed Cole’s home following the break in the case that has vexed and embarrassed the bureau for nearly five years.

Neighbors living near the suburban cul-de-sac described a young man who shunned most human interaction and doted on a pet Chihuahua.

“He’s very antisocial. Very,” a woman who said she had lived in the neighborhood since 1991 told The Post of Cole. “He keeps to himself.”

“He has a dog that he loves,” she added. “He walks every day, twice a day, to 7-Eleven with his dog and he wears his headphones.”

“He seemed very quiet. He would never make eye contact. Almost like he just didn’t see you,” added a second neighbor, a man who noted that Cole would “wear shorts all winter long, and red Crocs.”

FBI agents raiding Brian Cole’s house in Woodbridge, Va. on Dec. 4, 2025.AP
FBI agents searching Cole’s car.Andrew Thomas – CNP for NY Post
FBI agents preparing to enter Cole’s house in Woodbridge.Getty Images

“I’m pretty shocked,” said this neighbor, who lived in the area for seven years. “This is a very uncommonly friendly and neighborly place to live.”

According to a probable cause affidavit, bank account data showed the seemingly docile Cole was manufacturing his would-be instruments of death beginning in the fall of 2019 with the purchase of electrical wire, battery connectors and explosive caps from local retailers. He also bought steel wool, end caps and galvanized pipe throughout 2020.

Cole’s arrest comes one month before the fifth anniversary of the melee that briefly delayed congressional confirmation of Joe Biden’s election victory.

Surveillance footage showed a person carrying a backpack and wearing a gray hooded sweatshirt, mask, gloves, glasses, and a pair of Nike Air Max Speed Turf sneakers who planted what investigators called “viable explosive devices” at the headquarters of the two major parties on the night of Jan. 5, 2021.

The second neighbor said he doubted that Cole was the person recorded planting the bombs, claiming Cole has “uncommonly short legs” and a simple “gait analysis could rule him out or confirm” him as the culprit.

Prince William County police sealing the street during the raid.Getty Images

Law enforcement officials, led by Attorney General Pam Bondi, stressed that there was “no new tip” or “no new witness” that led to Cole’s arrest, with the AG crediting “good, diligent police work and prosecutorial work, working as a team along with the ATF, Capitol Police, the [DC] Metropolitan Police Department and of course, the FBI.”

FBI Director Kash Patel told reporters that investigators sifted through “three million lines of information … you can think about the amount of cell phone data that has to be ingested and triangulated and dumped and received.”

“When you develop evidence, you get a search warrant,” he added. “When you get a search warrant, you get an address. When you get an address, you hit the house, and that’s what we did.”

According to the probable cause affidavit filed Thursday afternoon, investigators used cell tower data to place Cole in the vicinity of Capitol Hill around the time the devices were planted.

The bombs were discovered the following afternoon — approximately 17 hours later and at around the same time Congress convened to count the 2020 electoral votes, a session which was suspended for several hours after supporters of President Trump broke into the Capitol and stormed the House and Senate chambers.

Then-Vice President-elect Kamala Harris and former House Speaker Nancy Pelosi (D-Calif.) both came “within feet” of the devices as they traveled to and from the DNC headquarters on South Capitol Street on Jan. 6.

In Pelosi’s case, her motorcade drove past one of the bombs after it was discovered by law enforcement, according to a congressional report that blamed law enforcement for failing to adequately secure the perimeter.

The arrest comes one month before the fifth anniversary of the melee that briefly delayed congressional confirmation of Joe Biden’s 2020 election victory.FBI
“Seeking Information” notice released by the FBI regarding the pipe bombs.AP
The suspect can be seen planting one of the bombs.Federal Bureau of Investigation
An explosive device with a timer and wires, found near the Republican National Committee office on Jan. 6, 2021.AP

That report, released in January of this year by Reps. Barry Loudermilk (R-Ga.) and Thomas Massie (R-Ky.), assessed that “little meaningful progress” had been made in the pipe bomb investigation and charged that the feds had “refused to provide substantive updates to Congress.”

Despite “a promising array of data and … numerous persons of interest,” the lawmakers’ report said, “[b]y the end of February 2021, the FBI began diverting resources away from the pipe bomb investigation.”

The same day the report was issued, investigators released additional information about the suspect — including video of the person planting one of the bombs and an estimate that the perp stood 5 feet 7 inches tall.

Video shows the 2021 DC pipe bombing suspect.FBI
Investigators released additional information about the suspect, such as the perp’s height.

The absence of a break in the case — or even clarification on whether the suspect was a man or woman — led to fervent speculation, mainly among conservatives and even some Republican lawmakers, that the failed bombing was the work of a far-left terrorist whose actions would cause embarrassment to a Biden administration whose Justice Department was pursuing charges against hundreds of Jan. 6 rioters.

Steven D’Antuono, the former head of the FBI’s Washington Field Office, fueled additional speculation when he told House Judiciary Committee lawmakers in a June 2023 transcribed interview that he was not sure the devices were ever meant to explode.

“I saw the same kitchen timer as you,” D’Antuono told Massie, who had asked whether the bombs were viable at the time they were discovered on Jan. 6. “I agree. I don’t know when they were supposed to go off. Maybe they weren’t supposed to go off. We can’t — we don’t know. We honestly don’t know.”

“Should it have exploded in the hour?” D’Antuono asked. “Or should it have been waiting there to — for somebody to find? Those are the theories that we have … There’s a lot of unanswered questions. There really are.”

Before joining the FBI, Bongino suggested last year on his popular podcast that the act was an “inside job” and involved a “massive cover-up.”

“Today’s arrest happened because the Trump administration has made this case a priority,” Bondi said. “The total lack of movement on this case in our nation’s capital undermined the public trust of our enforcement agenices. This cold case languished for four years until Director Patel and Deputy Director Bongino came to the FBI.”

“This is what happens,” Bongino added, “when you have a president who tells you to go get the bad guys.”

https://nypost.com/2025/12/04/us-news/fbi-makes-arrest-in-jan-6-pipe-bomb-investigation-after-nearly-5-years/

Cooper Companies initiates strategic review; shares jump

 Cooper Cos. (COO) soared 12% in after hours trading after initiating a strategic review of its businesses and naming a new board chair.

Cooper (COO) is undergoing a formal and comprehensive strategic review of ts businesses, corporate structure, strategy, operations, and capital allocation priorities, according to a statement on Thursday. The company will look at options including  partnerships, joint ventures, divestitures, mergers, business combinations, and other transactions.

The company named Colleen Jay as chairman to succeed Robert Weiss, effective Jan. 2. 

The business review comes after it was reported in October that activist investor Jana Partners took a stake and planned to push the company to review its strategic alternatives. Jana wants Cooper to combine its contact-lens unit with rival Bausch + Lomb (BLCO), the WSJ reported. 

During its strategic review, the company will focus on repurchasing shares under its recently announced $2 billion share repurchase program.

Cooper Cos. (COO) also reported Q4 results on Thursday. 

https://www.msn.com/en-us/money/companies/cooper-cos-jumps-after-starting-strategic-review-naming-new-board-chair/ar-AA1RJDFd

Canada and Mexico should not be export hubs for China, says USTR

 Canada and Mexico should not ​be used as export ‌hubs for China, Vietnam, Indonesia and ‌other countries, U.S. Trade Representative Jamieson Greer said on Thursday, saying that this was already ⁠happening in ‌some cases in Mexico.

Greer told a conference in ‍Washington that there were problems with the U.S.-Mexico-Canada trade agreement that ​he had helped negotiate ‌during President Donald Trump's first term, but some measures - including tariffs on foreign autos - were helping to correct issues.

Asked ⁠if the agreement ​would continue, Greer ​said it was the law of the land, a ‍law ⁠passed by Congress, and that Canada and Mexico were ⁠the United States' largest export destinations.

https://finance.yahoo.com/news/trump-may-demolish-another-trade-161620544.html

Cognitive Intervention Does More Than Defend Against Dementia

 Three ancillary studies to the U.S. POINTER trial collectively demonstrated that a structured 2-year lifestyle intervention for older adults at increased risk of cognitive decline led to better overall health.

In main results from the U.S. POINTER trial released in July, two lifestyle interventions -- one structured, the other self-guided -- improved cognitive scores in over 2,000 older adults, said Rema Raman, PhD, of the University of Southern California in Los Angeles, who co-chaired a symposium at the Clinical Trials on Alzheimer's Disease (CTAD) annual meeting.

Both 2-year interventions in U.S. POINTER encouraged physical activity, cognitive activity, healthy diet, social engagement, and cardiovascular health monitoring, but they differed in structure, intensity, and accountability.

The mean annual increase in global cognitive scores was greater in the structured group compared with the self-guided group (P=0.008). "The structured intervention may, in our opinion, slow the cognitive aging clock by about 1 to 2 years compared to the self-guided intervention," Raman said.

At CTAD, the first results reported from the trial's ancillary studies -- POINTER-NV (neurovascular), POINTER-Neuroimaging, and POINTER-zzz (sleep) -- showed that blood pressure regulation, cognitive resilience, and sleep apnea were better with the structured intervention.

"I am very encouraged by these early findings from the U.S. POINTER ancillary studies, which offer valuable insights into the physiological mechanisms that may have contributed to the positive results of the U.S. POINTER trial," said Richard Hodes, MD, director of the NIH's National Institute on Aging, which supported the research.

"The forthcoming publications and continued analysis of this rich dataset will deepen our understanding of how multimodal interventions can support brain health," Hodes said in a statement.

POINTER-NV

The POINTER-NV study showed that the structured intervention significantly enhanced blood pressure regulation, cerebral autoregulation, and vascular elasticity while also improving functional properties of the aorta and major cerebral arteries, reported principal investigator Tina Brinkley, PhD, of the Wake Forest University School of Medicine in Winston-Salem, North Carolina.

Baroreflex sensitivity, which measures a mechanism that regulates blood pressure and ultimately drives cerebral blood flow, was a key outcome. In the structured intervention group, baroreflex sensitivity improved by 1.177 ms/mm Hg (95% CI 0.634-1.720) over 2 years, representing a 14% increase, Brinkley said. In the self-guided group, the change in baroreflex sensitivity was not significant.

The findings indicate that a structured multidomain lifestyle intervention can improve the body's ability to regulate blood pressure, which is crucial for proper brain blood flow to the brain, Brinkley said.

POINTER-Neuroimaging

In POINTER-Neuroimaging, participants with high-risk profiles -- those who had low baseline hippocampal volume or entorhinal tau accumulation in the brain -- had greater cognitive benefits from the structured versus the self-guided intervention (P=0.006).

Amyloid status did not appear to affect the cognitive benefit of the intervention. "This means that people with amyloid build-up experienced the same benefits from the intervention as those without amyloid," said Susan Landau, PhD, of the University of California Berkeley, who led the ancillary study.

The structured and self-guided groups did not differ overall on 2-year changes in amyloid, tau, hippocampal volume, or white matter hyperintensity volume, Landau noted. However, the structured intervention showed a protective effect on cognitive function, reducing the effect of entorhinal tau as it accumulated, she said. A 4-year extension study to follow these biomarkers is underway.

POINTER-zzz

In POINTER-zzz, participants had sleep assessments at baseline, 12 months, and 24 months. At baseline, 63% had least mild sleep apnea, reported Laura Baker, PhD, also of the Wake Forest University School of Medicine.

Home-based sleep testing revealed that, over 2 years, the structured intervention group had a reduction of one to two respiratory disturbance events per hour relative to the self-guided group. In the structured group, the mean 2-year reduction in the apnea-hypopnea index (AHI) from baseline was 1.759 (95% CI -2.554 to -0.965). In the self-guided group, the difference was not significant.

The structured intervention benefit on AHI was consistent across several key subgroups and tended to be stronger for people with more severe baseline sleep apnea, Baker noted. These improvements in sleep-disordered breathing are clinically meaningful and may confer additional neuroprotective benefits, she said.

Data about other metrics, including sleep fragmentation, are still being analyzed.

Overall, the ancillary study findings suggest that "the U.S. POINTER lifestyle intervention with structured support has substantial and significant health benefits beyond improving cognition, and the benefits are in areas known to lower risk of cognitive decline and dementia," observed Maria Carrillo, PhD, chief science officer of the Alzheimer's Association in Chicago, which supported the trial.

"Bottom line, we now have a more comprehensive picture of how the U.S. POINTER intervention affects brain health, and overall health, too," she added.

Disclosures

The U.S POINTER trial was supported by the Alzheimer's Association. The National Institute on Aging of the NIH supported the POINTER ancillary studies.

Brinkley had no disclosures.

Landau reported relationships with the NIH, Eisai, IMPACT-AD, Johnson & Johnson, ATRI, the Alzheimer's Association, and Shenzhen Bay Lab.

Baker had no disclosures.

Primary Source

Clinical Trials on Alzheimer's Disease

Secondary Source

Clinical Trials on Alzheimer's Disease

CDC Advisors Delay Hepatitis B Vaccine Vote Again

 CDC vaccine advisors again postponed their vote on changes to the hepatitis B vaccine schedule for infants, this time delaying it by 1 day after raising concerns about the precise wording of the measure they are considering.

Members of the Advisory Committee on Immunization Practices (ACIP) voted 7-3 Thursday to table the issue until Friday, citing confusion over voting language that one member said had been revised three times in 72 hours.

Several members opposed the delay. Newly appointed chair Kirk Milhoan, MD, PhD, did not record a vote; attending remotely, he appeared to lose connection during the vote.

The proposal under consideration would recommend shared clinical decision-making between clinicians and parents of infants born to mothers who test negative for hepatitis B surface antigen (HBsAg). Members said it was unclear whether that language referred narrowly to the birth dose or to the initiation of the full three-dose series, both of which appeared in the draft wording.

Under the same proposal, ACIP would continue recommending the birth dose for infants of HBsAg-positive mothers while stating that infants whose parents defer the birth dose not receive their first shot until 2 months of age.

The latest vote delay came nearly 3 months after members postponed a vote on changing their recommendations. It marked the seminal moment of a contentious meeting that unfolded 3 days after former chair Martin Kulldorff, PhD -- who used his first ACIP meeting to challenge the universal hepatitis B birth-dose recommendation -- left for a role at HHS. With Milhoan participating online, vice chair Robert Malone, MD, presided over the session.

Current U.S. recommendations call for a three-dose hepatitis B vaccine series administered at birth, 1-2 months, and 6 months or later. Pediatricians and infectious disease experts warn that delaying the start of that series would increase transmission risk. Chronic hepatitis B virus infection sharply increases the risk of cirrhosis and liver cancer.

"Let me be very clear about this: Delaying the birth dose would leave newborns unprotected during a critical window of their lives," said José R. Romero, MD, of the American Academy of Pediatrics. "Despite what HHS Secretary Robert F. Kennedy Jr. and some ACIP members suggested today, the science is unequivocal. Hepatitis B remains a real and serious risk to infants."

Vicky Pebsworth, PhD, RN -- an executive for the National Vaccine Information Center (formerly Dissatisfied Parents Together), a group widely considered to be a spreader of vaccine misinformation -- said the childhood immunization schedule workgroup had endorsed a shared clinical decision-making approach for infants of HBsAg-negative mothers.

She cited uncertainty around incidence, prevalence, and horizontal transmission; questions about whether all three doses are necessary; and what she described as poor-quality evidence on safety. She said the "overwhelming majority" of infants born to HBsAg-negative mothers do not face high infection risk in the first months of life, and presented a slide stating that the 1991 universal birth-dose recommendation "was made in error."

However, a comprehensive review by the Vaccine Integrity Project released this week found no evidence of any safety or efficacy benefits in delaying the birth dose and concluded that delaying vaccination would "needlessly endanger" infants. Since the adoption of the birth-dose recommendation, infant hepatitis B virus infections have been nearly eliminated and pediatric infections in the U.S. have dropped by more than 95%.

Some ACIP members "spoke without evidence," Romero said, "and in most cases, they were just downright wrong."

A previous recommendation change -- in 1999, when the American Academy of Pediatrics and the U.S. Public Health Service recommended delaying hepatitis B vaccination for infants of HBsAg-negative mothers -- was linked to at least one documented death, according to a Morbidity and Mortality Weekly Report that detailed the case of a 3-month-old Michigan girl who died of fulminant hepatitis B after her mother's infection status was incorrectly recorded during prenatal care.

Two of the meeting's first three presenters -- author Mark Blaxill, MBA, and climate researcher Cynthia Nevison, PhD -- co-authored a 2021 study on autism retracted by the Journal of Autism and Developmental Disorders for methodological flaws and undisclosed conflicts of interest.

Nevison -- a CDC contractor who assisted the panel's hepatitis B workgroup -- argued that the universal birth dose should not receive credit for declines in infection rates seen over three decades, asserting that those reductions did not appear until 2012. Her position contradicted CDC scientists who said in September that apparent plateaus reflect generational shifts in exposure. Nevison instead attributed declines to blood-safety screening improvements, safer sex practices, needle-exchange programs, and case management for HBsAg-positive mothers.

"The answer to the question of which has had more effect -- the universal birth dose or other, more targeted measures -- logically, when you look at the age range in which the biggest declines have occurred, it had to be other measures," Nevison said.

Panelist H. Cody Meissner, MD, of the Geisel School of Medicine at Dartmouth in Hanover, New Hampshire, rejected that interpretation. "This disease has gone down in the United States thanks to the effectiveness of our current immunization program," he said.

"In your opinion," Malone interjected.

Meissner replied, "These are facts, Robert."

Blaxill -- who chairs an anti-vaccine group but was listed on the agenda as representing the CDC -- described himself as a "critic of the CDC" and questioned vaccine safety, calling evidence "limited" and "often concerning." He cited Vaccine Injury Compensation Program (VICP) claim numbers and rodent-model injury mechanisms. Meissner -- a former VICP chair -- pushed back, noting that "there is no evidence of harm" and that VICP settlements are not confirmations of causality. "These are not confirmed associations," he said.

However, Jason Goldman, MD, president of the American College of Physicians, delivered the sharpest rebuke.

He blasted the panel for having "no understanding of the process or the gravity of the moment," questioned why the hepatitis B vaccine workgroup roster had not been disclosed, and called the proceedings "completely inappropriate" with presenters advancing an "anti-vaccine agenda" without necessary evidence.

"The best thing you can do is adjourn the meeting and discuss vaccine issues that actually need to be taken up," Goldman said.

https://www.medpagetoday.com/pediatrics/vaccines/118839

'Ultrasound Can Aid Treatment of Vascular Complications From Cosmetic Fillers'

 Amid a rise in the use of cosmetic fillers -- commonly injected in the face for anti-aging effects -- Doppler high-frequency ultrasound (HFUS) picked up "highly variable" findings in filler-related vascular adverse events (VAEs), researchers reported.

Among 100 participants in an international retrospective cross-sectional study, the most common VAEs were absent flow in perforator vessels (42%) and absent flow in major vessels (35%), reported Rosa Maria Silveira Sigrist, MD, of the University of São Paulo Department of Radiology in Brazil, at the Radiological Society of North America (RSNA) annual meeting in Chicago.

Beyond these, though, "the findings are highly variable," which, she said, "highlights the need to recognize all possible Doppler patterns to support diagnosis and guide management."

The next most common VAEs identified were compensatory flow in adjacent or branching vessels (26%), string sign (18%), and increased peak systolic velocity (16%). Doppler abnormalities moderately correlated with absent flow in the lateral nasal artery (Φ=0.37, P=0.00042) and columellar artery (Φ=0.34, P=0.00136) -- both high-risk arteries for necrosis and visual complications, Sigrist added.

"We know that the use of cosmetic fillers has been growing a lot, and so [have] the vascular complications, including necrosis, blindness, and even stroke," Sigrist said during the presentation. "And unlike other systems, like the carotid or peripheral vessels, where Doppler criteria for stenosis and occlusions are very well established, for the face things are different. The facial vasculature is highly complex and extremely anastomosed, and we lack standardized Doppler criteria for these complications."

"Our main objectives were to identify the most frequent findings related to vascular complications to support diagnosis and management, and also to evaluate whether these findings are associated with the use of hyaluronidase, which is the enzyme that breaks down hyaluronic acid [a common filler material]," she said.

Most study participants had been injected with hyaluronic acid. But, there were no differences in Doppler findings between the 79% of participants who received hyaluronidase before ultrasound imaging and the 21% who did not get these injections to treat filler-related complications. Nor did hyaluronidase prior to ultrasound imaging significantly correlate with any specific Doppler findings, Sigrist reported.

The study involved patients seen for VAEs from May 2022 through April 2025 by four radiologists in Brazil, Chile, and Colombia, one aesthetic medical doctor in the Netherlands, and one plastic surgeon in the U.S. Participants in the study had an average age of 38 and 88% were female. These medical professionals completed a structured questionnaire on their Doppler use.

There was heterogeneity in terms of how Doppler HFUS was used by examiners, indicating a need for standardized facial Doppler protocols for reproducibility and optimal outcomes, Sigrist noted.

Only half of examiners used microvascular Doppler technologies, Sigrist highlighted. "What was really a surprise to me," she said, "is that the criteria for peak systolic velocity in facial vascular occlusions ... we did not have a consensus on that." Related findings included that "half of the examiners did not know which reference value to use for these complications," she noted.

One question from the audience pertained to why Doppler HFUS might be better than MRI or CT imaging when it comes to filler-related VAEs. Sigrist pointed to a number of potential factors, including that Doppler HFUS doesn't require contrast, that ultrasound imaging is more readily available than the other imaging modalities, and that the availability of microvascular technologies is important, as is having real-time examination in patients.

Disclosures

Sigrist reported consultant fees from GE Healthcare. Co-authors also reported consultant and speaker fees as well as other relationships with industry.

NYC Mayor Eric Adams Issues Order Banning Israel Divestment

 


New York City Mayor Eric Adams issued a pair of executive orders aimed at addressing antisemitism, his office said, weeks before Zohran Mamdani takes his place.

Adams, who recently returned from a trip to Israel, issued an executive order prohibiting city agency heads and mayoral appointees from “engaging in procurement practices that discriminate against the State of Israel, Israeli citizens, or those associated with Israel.” It also bars city pension administrators and trustees from “opposing divestment from bonds and other assets that would discriminate against the State of Israel, Israeli citizens, or those associated with Israel,” the order states.

https://www.bloomberg.com/news/articles/2025-12-04/nyc-mayor-eric-adams-issues-order-banning-israel-divestment